Quick Answer
UTAH MEDICAL PRODUCTS INC reported Cash And Cash Equivalents At Carrying Value of $85.76 million for the year ending 2025.
- UTAH MEDICAL PRODUCTS INC showed an increase of +3.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from UTAH MEDICAL PRODUCTS INC's annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), UTAH MEDICAL PRODUCTS INC's Cash And Cash Equivalents At Carrying Value has grown by 20,816.1%.
- Historical annual values: Fiscal year 2025: $85.76 million | Fiscal year 2024: $82.98 million | Fiscal year 2023: $92.87 million | Fiscal year 2022: $75.05 million | Fiscal year 2021: $60.97 million | Fiscal year 2020: $51.59 million | Fiscal year 2019: $42.79 million | Fiscal year 2018: $51.11 million | Fiscal year 2017: $39.88 million | Fiscal year 2016: $26.30 million | Fiscal year 2015: $23.28 million | Fiscal year 2014: $19.27 million | Fiscal year 2013: $14.40 million | Fiscal year 2012: $8.87 million | Fiscal year 2011: $6.53 million | Fiscal year 2010: $3.82 million | Fiscal year 2009: $410.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: